Brief: Biomx Reports Q3 Loss of $0.23 Per Share
Nov 9 (Reuters) - Biomx Inc PHGE.A :
* BIOMX REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES
BUSINESS UPDATE
* BIOMX INC - CASH RUNWAY THROUGH AT LEAST MID-2024
* BIOMX INC - QTRLY LOSS PER SHARE $0.23
* BIOMX INC - CONTINUED PROGRESS ENROLLING PATIENTS IN PHASE
1/2
TRIAL OF BX004 FOR TREATMENT OF LUNG INFECTIONS IN CYSTIC
FIBROSIS
* BIOMX INC - RESULTS FROM PART 1 OF PHASE 1/2 TRIAL OF
BX004 NOW
EXPECTED IN Q1 2023
Source text for Eikon: ID:nGNX8gs4WG
Further company coverage: PHGE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tessera Defense and Homeland Security
See all newsBrief: Tessera Defense & Homeland Security - Enters $5 Million Revolving Credit Agreement With Mandragola On Oct 5, 2026 - SEC Filing
Brief: Biomx - Announces One-For-Ten Reverse Stock Split Of Common Stock - SEC Filing
Brief: Biomx And Water.Io Agree To Updated Zorronet Acquisition Terms
Brief: BiomX - May Offer And Sell Up To $9.10 Million Of Common Stock Through Wainwright - SEC Filing
Brief: Biomx Provides Update On Defense Technology Portfolio And Growth Strategy